Steroidogenic control of liver metabolism through a nuclear receptor-network

Objective: Coupling metabolic and reproductive pathways is essential for the survival of species. However, the functions of steroidogenic enzymes expressed in metabolic tissues are largely unknown. Methods and results: Here, we show that in the liver, the classical steroidogenic enzyme Cyp17a1 forms...

Full description

Bibliographic Details
Main Authors: Alexandra Milona, Vittoria Massafra, Harmjan Vos, Jyoti Naik, Natalia Artigas, Helen A.B. Paterson, Ingrid T.G.W. Bijsmans, Ellen C.L. Willemsen, Jose M. Ramos Pittol, Irene Miguel-Aliaga, Piter Bosma, Boudewijn M.T. Burgering, Catherine Williamson, Santiago Vernia, Waljit S. Dhillo, Saskia W.C. van Mil, Bryn M. Owen
Format: Article
Language:English
Published: Elsevier 2019-12-01
Series:Molecular Metabolism
Online Access:http://www.sciencedirect.com/science/article/pii/S221287781930910X
id doaj-f03fe7de90804886b4db2443d1f7e1c8
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Alexandra Milona
Vittoria Massafra
Harmjan Vos
Jyoti Naik
Natalia Artigas
Helen A.B. Paterson
Ingrid T.G.W. Bijsmans
Ellen C.L. Willemsen
Jose M. Ramos Pittol
Irene Miguel-Aliaga
Piter Bosma
Boudewijn M.T. Burgering
Catherine Williamson
Santiago Vernia
Waljit S. Dhillo
Saskia W.C. van Mil
Bryn M. Owen
spellingShingle Alexandra Milona
Vittoria Massafra
Harmjan Vos
Jyoti Naik
Natalia Artigas
Helen A.B. Paterson
Ingrid T.G.W. Bijsmans
Ellen C.L. Willemsen
Jose M. Ramos Pittol
Irene Miguel-Aliaga
Piter Bosma
Boudewijn M.T. Burgering
Catherine Williamson
Santiago Vernia
Waljit S. Dhillo
Saskia W.C. van Mil
Bryn M. Owen
Steroidogenic control of liver metabolism through a nuclear receptor-network
Molecular Metabolism
author_facet Alexandra Milona
Vittoria Massafra
Harmjan Vos
Jyoti Naik
Natalia Artigas
Helen A.B. Paterson
Ingrid T.G.W. Bijsmans
Ellen C.L. Willemsen
Jose M. Ramos Pittol
Irene Miguel-Aliaga
Piter Bosma
Boudewijn M.T. Burgering
Catherine Williamson
Santiago Vernia
Waljit S. Dhillo
Saskia W.C. van Mil
Bryn M. Owen
author_sort Alexandra Milona
title Steroidogenic control of liver metabolism through a nuclear receptor-network
title_short Steroidogenic control of liver metabolism through a nuclear receptor-network
title_full Steroidogenic control of liver metabolism through a nuclear receptor-network
title_fullStr Steroidogenic control of liver metabolism through a nuclear receptor-network
title_full_unstemmed Steroidogenic control of liver metabolism through a nuclear receptor-network
title_sort steroidogenic control of liver metabolism through a nuclear receptor-network
publisher Elsevier
series Molecular Metabolism
issn 2212-8778
publishDate 2019-12-01
description Objective: Coupling metabolic and reproductive pathways is essential for the survival of species. However, the functions of steroidogenic enzymes expressed in metabolic tissues are largely unknown. Methods and results: Here, we show that in the liver, the classical steroidogenic enzyme Cyp17a1 forms an essential nexus for glucose and ketone metabolism during feed-fast cycles. Both gain- and loss-of-function approaches are used to show that hepatic Cyp17a1 is induced by fasting, catalyzes the production of at least one hormone-ligand (DHEA) for the nuclear receptor PPARα, and is ultimately required for maintaining euglycemia and ketogenesis during nutrient deprivation. The feedback-loop that terminates Cyp17a1-PPARα activity, and re-establishes anabolic liver metabolism during re-feeding is mapped to postprandial bile acid-signaling, involving the receptors FXR, SHP and LRH-1. Conclusions: Together, these findings represent a novel paradigm of homeostatic control in which nutritional cues feed-forward on to metabolic pathways by influencing extragonadal steroidogenesis. Keywords: FXR, FGF21, Bile acids, Liver, Metabolism, Fasting, Gluconeogenesis, Diabetes, Steroidogenesis, Cyp17a1
url http://www.sciencedirect.com/science/article/pii/S221287781930910X
work_keys_str_mv AT alexandramilona steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork
AT vittoriamassafra steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork
AT harmjanvos steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork
AT jyotinaik steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork
AT nataliaartigas steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork
AT helenabpaterson steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork
AT ingridtgwbijsmans steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork
AT ellenclwillemsen steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork
AT josemramospittol steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork
AT irenemiguelaliaga steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork
AT piterbosma steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork
AT boudewijnmtburgering steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork
AT catherinewilliamson steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork
AT santiagovernia steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork
AT waljitsdhillo steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork
AT saskiawcvanmil steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork
AT brynmowen steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork
_version_ 1724722318880538624
spelling doaj-f03fe7de90804886b4db2443d1f7e1c82020-11-25T02:54:17ZengElsevierMolecular Metabolism2212-87782019-12-0130221229Steroidogenic control of liver metabolism through a nuclear receptor-networkAlexandra Milona0Vittoria Massafra1Harmjan Vos2Jyoti Naik3Natalia Artigas4Helen A.B. Paterson5Ingrid T.G.W. Bijsmans6Ellen C.L. Willemsen7Jose M. Ramos Pittol8Irene Miguel-Aliaga9Piter Bosma10Boudewijn M.T. Burgering11Catherine Williamson12Santiago Vernia13Waljit S. Dhillo14Saskia W.C. van Mil15Bryn M. Owen16MRC London Institute of Medical Sciences (LMS), London, United Kingdom; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, United KingdomCenter for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, the NetherlandsCenter for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, the NetherlandsAmsterdam UMC, University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, AG&M, Meibergdreef 69-71, 1105 BK, Amsterdam, the NetherlandsMRC London Institute of Medical Sciences (LMS), London, United Kingdom; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, United KingdomMRC London Institute of Medical Sciences (LMS), London, United Kingdom; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, United KingdomCenter for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, the NetherlandsCenter for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, the NetherlandsCenter for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, the NetherlandsMRC London Institute of Medical Sciences (LMS), London, United Kingdom; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, United KingdomAmsterdam UMC, University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, AG&M, Meibergdreef 69-71, 1105 BK, Amsterdam, the NetherlandsCenter for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, the NetherlandsSchool of Life Course Science, Kings College London, London, United KingdomMRC London Institute of Medical Sciences (LMS), London, United Kingdom; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, United KingdomSection of Endocrinology & Investigative Medicine, Division of Diabetes, Endocrinology, and Metabolism, Department of Metabolism, Digestion, and Reproduction, Imperial College London, London, United KingdomCenter for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands; Amsterdam UMC, University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, AG&M, Meibergdreef 69-71, 1105 BK, Amsterdam, the Netherlands; Corresponding author. UMC Utrecht Center for Molecular Medicine, PO Box 85060, 3508 AB, Utrecht, the Netherlands.Section of Endocrinology & Investigative Medicine, Division of Diabetes, Endocrinology, and Metabolism, Department of Metabolism, Digestion, and Reproduction, Imperial College London, London, United Kingdom; Corresponding author. Section of Investigative Medicine, Imperial College London, Du Cane Road, London, W12 0NN, United Kingdom.Objective: Coupling metabolic and reproductive pathways is essential for the survival of species. However, the functions of steroidogenic enzymes expressed in metabolic tissues are largely unknown. Methods and results: Here, we show that in the liver, the classical steroidogenic enzyme Cyp17a1 forms an essential nexus for glucose and ketone metabolism during feed-fast cycles. Both gain- and loss-of-function approaches are used to show that hepatic Cyp17a1 is induced by fasting, catalyzes the production of at least one hormone-ligand (DHEA) for the nuclear receptor PPARα, and is ultimately required for maintaining euglycemia and ketogenesis during nutrient deprivation. The feedback-loop that terminates Cyp17a1-PPARα activity, and re-establishes anabolic liver metabolism during re-feeding is mapped to postprandial bile acid-signaling, involving the receptors FXR, SHP and LRH-1. Conclusions: Together, these findings represent a novel paradigm of homeostatic control in which nutritional cues feed-forward on to metabolic pathways by influencing extragonadal steroidogenesis. Keywords: FXR, FGF21, Bile acids, Liver, Metabolism, Fasting, Gluconeogenesis, Diabetes, Steroidogenesis, Cyp17a1http://www.sciencedirect.com/science/article/pii/S221287781930910X